Showing results (21-30 of 103) with videos related to
Sort By:
Pageof 11
The American Journal of Medicine|September 1, 1987
Salvage therapy of advanced Hodgkin's disease. Critical appraisal of curative potentialA C Buzaid, S M Lippman, T P MillerCancer Treatment Reports|January 1, 1980
Extensive adenocarcinoma and large cell undifferentiated carcinoma of the lung treated with 5-FU, vincristine, and mitomycin C (FOMi)T P Miller, L J McMahon, R B LivingstonThe Cancer Journal From Scientific American|July 22, 1998
New REAL clinical entitiesR I Fisher, T P Miller, T M GroganNeuropsychobiology|January 1, 1988
A comparison of assessment techniques measuring the effects of methylphenidate, secobarbital, diazepam and diphenhydramine in abstinent alcoholicsT P Miller, J L Taylor, J R TinklenbergInvestigational New Drugs|January 1, 1984
Phase II trial of bisantrene in patients with intermediate and high grade diffuse non-Hodgkin's lymphomasT P Miller, S E Jones, D S Alberts, et al.Cancer Chemotherapy and Pharmacology|January 1, 1984
Evaluation of anticancer drug schedule dependency using an in vitro human tumor clonogenic assayR Ludwig, D S Alberts, T P Miller, et al.Hematology/Oncology Clinics of North America|October 23, 1997
Follicular lymphomas: do histologic subtypes predict outcome?T P Miller, M LeBlanc, T M Grogan, et al.Annals of Allergy|April 1, 1993
Allergic bronchopulmonary aspergillosis in patients with and without evidence of bronchiectasisP A Greenberger, T P Miller, M Roberts, et al.Cancer Treatment Reports|September 1, 1986
Extensive non-small cell lung cancer treated with mitomycin, cisplatin, and vindesine (MiPE): a Southwest Oncology Group StudyT P Miller, R B Vance, F R Ahmann, et al.Leukemia|March 1, 1993
Deficient tumor-infiltrating T-lymphocyte response in malignant lymphoma: relationship to HLA expression and host immunocompetenceA F List, C M Spier, T P Miller, et al.Pageof 11